Skip to main content

HCW Biologics (US:HCWB) — Company Overview, News & Financial Data

HCW Biologics logo
HCWBHCW Biologics
HCW Biologics primary media
Company profile

HCW Biologics

About

Explore United States companies

HCW Biologics (NASDAQ:HCWB) is a clinical-stage company developing immunotherapies to combat chronic, low-grade inflammation, a hallmark of aging and many diseases. Their focus is on disrupting this inflammatory process to improve healthspan, essentially the length of healthy life. They're currently in the development phase of novel immunotherapeutic drugs and haven't launched any commercial products yet. HCW Biologics is a small-cap company with a market capitalization around $41 million.

Snapshot

Public USOwnership
2018Year founded
45Employees
Miramar, United StatesHead office
Loading Map...
Global footprint

Operations

All Locations
Miramar, US

Products and/or services of HCW Biologics

  • Immunotherapy Research & Development: HCW Biologics researches and develops novel immunotherapy drugs targeting chronic, low-grade inflammation.
  • Pre-Clinical and Clinical Trials: They conduct pre-clinical studies in labs and potentially clinical trials to test the safety and efficacy of their drug candidates.
  • Collaboration with Research Institutions: HCW Biologics might collaborate with other research institutions to advance their discoveries.
  • Data Analysis & Reporting: They analyze data from studies and trials, reporting findings to regulators and the scientific community.
  • Investor Relations & Communication: HCW Biologics communicates with investors regarding their progress and developments.
  • Intellectual Property Management: The company likely manages patents and other intellectual property related to their discoveries.

HCW Biologics executive team

  • Dr. Hing C. Wong Ph.D.Founder, CEO, Director & Secretary
  • Ms. Rebecca Byam CPA, M.B.A.Chief Financial Officer
  • Dr. Peter Rhode Ph.D.Chief Scientific Officer & VP of Clinical Operations
  • Ms. Nicole Valdivieso Esq.Vice President of Legal Affairs
  • Mr. Lee D. FlowersSenior Vice President of Business Development